PHARMACYTE BIOTECH INC's ticker is PMCBD and the CUSIP is 71715X203. A total of 31 filers reported holding PHARMACYTE BIOTECH INC in Q3 2022. The put-call ratio across all filers is 1.61 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $111 | -79.0% | 53 | -71.4% | 0.00% | – |
| Q2 2023 | $529 | +41.1% | 185 | +43.4% | 0.00% | – |
| Q1 2023 | $375 | -9.2% | 129 | -8.5% | 0.00% | – |
| Q4 2022 | $413 | – | 141 | +2.2% | 0.00% | – |
| Q3 2022 | $0 | – | 138 | -0.7% | 0.00% | – |
| Q2 2022 | $0 | – | 139 | +8.6% | 0.00% | – |
| Q1 2022 | $0 | – | 128 | +0.8% | 0.00% | – |
| Q4 2021 | $0 | – | 127 | +388.5% | 0.00% | – |
| Q3 2021 | $0 | – | 26 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 1,061,411 | $2,378,000 | 1.62% |
| Ayrton Capital LLC | 153,130 | $343,000 | 0.56% |
| Shay Capital LLC | 982,698 | $2,201,000 | 0.44% |
| EQUITEC PROPRIETARY MARKETS, LLC | 342,994 | $768,000 | 0.22% |
| FNY Investment Advisers, LLC | 15,290 | $34,000 | 0.02% |
| K2 PRINCIPAL FUND, L.P. | 91,095 | $204,000 | 0.02% |
| Schonfeld Strategic Advisors LLC | 26,200 | $59,000 | 0.00% |
| Aspire Private Capital, LLC | 800 | $2,000 | 0.00% |
| OSAIC HOLDINGS, INC. | 1,758 | $3,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 1,734 | $4,000 | 0.00% |